“The counterfeit drug crisis is not merely a regulatory failure. It is a dignity crisis. When a sick Nigerian buys medicine, they are not just purchasing a product…”
Mrs. Chioma Okafor, a petty trader in Lagos, still remembers the afternoon her seven-year-old daughter collapsed after taking anti-malarial medication. She had bought the drugs from a familiar market vendor — cheaper than the pharmacy, but from someone she trusted.
“I thought I was being smart,” she says quietly. “I didn’t know I was poisoning my child.”
Her daughter survived, but only after weeks in hospital.
Tests later showed the medicine contained little more than chalk and colouring. The active ingredient that could have saved her life was nowhere to be found.
Chioma’s story is not unique. It is happening in market stalls, corner shops, and even some pharmacies across Nigeria today. And it is a story not just of public health failure, but of a profound violation of human dignity.
The Counterfeit Crisis At Our Doorstep
In March 2026, the National Agency for Food and Drug Administration and Control (NAFDAC) issued two urgent public alerts confirming counterfeit batches of Avastin 400mg — a cancer drug used to treat recurrent glioblastoma — circulating in Nigeria.
The counterfeit vials, bearing batch numbers that did not exist in the manufacturer’s database, were sold at prices ranging from ₦180,000 to ₦350,000. They featured incorrect artwork, misspelled text, and tamper-evident labels that did not match genuine products. Because no physical samples were returned for chemical analysis, NAFDAC could not determine whether these vials contained any active ingredient at all — or something far worse.
Days later, NAFDAC confirmed a counterfeit batch of Herceptin 600mg — a drug used to treat breast and stomach cancer — offered by a pharmacist in Lagos at a suspiciously low price of ₦50,000. The batch number, A8519B34, was fake. The 2D matrix code was wrong. The expiry date was incorrect. A cancer patient injecting this substance would receive not lifesaving therapy, but a cruel placebo — or worse.
And in January 2026, NAFDAC alerted the public to unauthorised Risperdal 2mg tablets — used to treat schizophrenia and bipolar disorder — diverted from the Turkish market and circulating in Kaduna State.
The product, intended for sale in Turkey, had been illegally rerouted into Nigeria’s supply chain. For a patient with bipolar disorder, taking a drug of unknown origin and stability is not merely risky; it is potentially catastrophic.
These three alerts, all within the first quarter of 2026, are not coincidences. They are symptoms of a systemic crisis.
The Human Cost
The World Health Organisation (WHO) estimates that substandard and falsified medical products cause over 100,000 deaths annually across Africa. A 2024 UN Office on Drugs and Crime study suggests that up to 500,000 people die annually from counterfeit drugs in sub-Saharan Africa alone — including 267,000 deaths from sub-standard malaria drugs and 169,000 from fake antibiotics used to treat childhood pneumonia.
Behind every number is a human being. A mother buying cough syrup for her child. A cancer patient pinning their last hopes on an injection. A man with schizophrenia taking his daily medication to stay stable. Each of these Nigerians is entitled to the dignity of knowing that their medicine is real. When the state fails to guarantee this, it fails in its most basic duty of care.
The Legal Framework: Strong On Paper, Weak In Practice
Nigeria has laws that should prevent this. The NAFDAC Act (Cap N1, Laws of the Federation of Nigeria 2004) prohibits the manufacture, importation, advertisement, sale, distribution, or use of any drug that has not been registered with the agency. No drug may enter Nigeria without NAFDAC’s Port Inspectorate Directorate conducting physical inspection and clearance at the point of entry.
The Counterfeit and Fake Drugs and Unwholesome Processed Foods (Miscellaneous Provisions) Act imposes severe penalties — including imprisonment and fines — for trafficking in counterfeit medicines.
The National Health Act, 2014 contains provisions affirming patient rights, including the right to receive healthcare services that meet minimum standards of safety and quality.
And the Nigeria Data Protection Act, 2023, drawing its constitutional authority from Section 37 of the 1999 Constitution (which guarantees the right to privacy), establishes a framework for protecting personal data — including the health data that flows through digital pharmacovigilance systems like NAFDAC’s MedSafety App.
Yet here is the uncomfortable truth: having laws on paper is not the same as having protection in practice.
How The Fakes Get In
Nigeria’s pharmaceutical market is substantially import-dependent, with medicines sourced from India, China, and Europe. Every legitimate consignment must pass through a rigorous process: registration on NAFDAC’s National Product Authentication and Monitoring System (NAPAMS) portal, dossier evaluation, laboratory analysis, facility inspection, and finally port clearance with physical inspection.
So how do counterfeit Avastin and Herceptin vials end up in Nigerian hospitals and pharmacies?
The answer lies in the gaps between the law and its enforcement. Counterfeiters exploit weak border controls, compromised officials, and a supply chain where legitimate and illegitimate products sometimes share the same distribution channels.
A March 2026 editorial in The Guardian Nigeria noted that the seizure of counterfeit drugs worth over ₦3 billion suggests “a well-financed network with vast storage, logistics, supply links and distribution channels” — one confident enough to stock billions of naira in fake medicines because it knows demand is high and detection is low.
The U.S. State Department’s travel advisory explicitly warns that “counterfeit pharmaceuticals are a common problem” in Nigeria and advises travelers to bring their own medications. When a foreign government’s official travel guidance tells its citizens not to trust Nigerian pharmacies, we must confront the scale of our failure.
Dignity Of The Vulnerable
The counterfeit drug crisis is not merely a regulatory failure. It is a dignity crisis.
When a sick Nigerian buys medicine, they are not just purchasing a product. They are purchasing trust — trust that the state has ensured the product is safe, trust that the pharmacist has verified its source, trust that the label tells the truth. When that trust is betrayed, the violation is not just economic. It is existential.
Consider the cancer patient paying ₦350,000 for counterfeit Avastin. They are not merely losing money. They are losing time — the narrow window in which effective treatment might have worked. They are losing hope — the hope that their government, their healthcare system, and their pharmacist are on their side. They are losing dignity — the dignity of being treated as a person worthy of protection, not as a mark to be exploited by criminals.
Consider the mother buying anti-malarials for her child. When the drug contains only chalk, she has not merely wasted her money. She has been deceived at her most vulnerable moment — when her child’s life is in her hands, and she turns to the market for help.
This is why counterfeit drugs are not just a public health issue. They are a human rights issue. And health law must rise to meet them.
What Must Be Done
So where do we go from here? How do we restore the dignity of the Nigerian patient?
First, NAFDAC’s enforcement capacity must be urgently strengthened. The agency’s port inspection, post-market surveillance, and forensic laboratory capabilities need dedicated funding and modern technology. Inter-agency coordination among NAFDAC, Customs, and port authorities must be hardened against compromise.
Second, penalties for counterfeit drug trafficking must be severe and swiftly applied. The existing legal framework provides for imprisonment and fines, but prosecution is rare and slow.
The National Human Rights (NHRC) Commission has expressed concern over proposals for the death penalty — but the current situation, where traffickers operate with near-impunity, is equally unacceptable. The law must be enforced, and enforcement must be visible.
Third, the supply chain must be made transparent and traceable. Digital tracking systems — from manufacturer to patient — can prevent falsified products from hiding behind paperwork. NAFDAC’s NAPAMS portal and e-license systems are a start, but they must be expanded to cover every vial, every tablet, every bottle.
Fourth, public awareness must be raised. Nigerians must know that cheap medicine from an unverified source is not a bargain — it is a gamble with their lives. NAFDAC’s public alerts, hotlines (08001623322), and MedSafety App must be promoted aggressively rather than buried on government websites.
Fifth, and most importantly, we must resist the normalisation of this crisis. When counterfeit drugs become so common that we treat them as inevitable, we have surrendered the dignity of our people to criminal enterprise. The measure of a health system is not the sophistication of its hospitals or the number of its doctors. It is whether the poorest Nigerian, buying medicine in the most remote market, can trust what is in their hand.
A Final Thought
Mrs. Chioma Okafor’s daughter survived. But she carries the trauma of those weeks in hospital — and the knowledge that her child’s suffering was entirely preventable. “I didn’t know I was poisoning my child,” she said. No mother should have to say those words. No patient should have to wonder whether their cancer drug is real. No person with mental illness should have to fear that their medication will make them worse.
Health law is not just about regulating factories and licensing pharmacies. At its core, it is about protecting the dignity of the human person — especially at their most vulnerable. When a Nigerian buys medicine, they are placing their life in the hands of the state. The state must be worthy of that trust. The medicine in your hand is your dignity. Guard it well.
•Sanu is a Nigerian lawyer and health law scholar. This column breaks down complex health laws for everyday Nigerians.
